Erythromycin Impurity, with the CAS number 40554-78-7, is a chemical compound associated with the antibiotic erythromycin, which is derived from the bacterium Saccharopolyspora erythraea. This impurity typically arises during the synthesis or degradation of erythromycin and may exhibit similar structural features to the parent compound. Characteristically, it may possess a macrolide structure, which includes a large lactone ring and multiple sugar moieties. The presence of impurities like this can affect the efficacy and safety of pharmaceutical formulations, necessitating rigorous quality control measures in drug manufacturing. Erythromycin Impurity may also exhibit varying degrees of biological activity, potentially influencing its pharmacological profile. Its identification and quantification are crucial in ensuring the purity of erythromycin products, as impurities can lead to adverse effects or reduced therapeutic efficacy. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to detect and characterize such impurities in pharmaceutical contexts.

Erythromycin Impurity

40554-78-7: Erythromycin Impurity, with the CAS number 40554-78-7, is a chemical compound associated with the antibiotic erythromycin, which is derived from the bacterium Saccharopolyspora erythraea. This impurity typically arises during the synthesis or degradation of erythromycin and may exhibit similar structural features to the parent compound. Characteristically, it may possess a macrolide structure, which includes a large lactone ring and multiple sugar moieties. The presence of impurities like this can affect the efficacy and safety of pharmaceutical formulations, necessitating rigorous quality control measures in drug manufacturing. Erythromycin Impurity may also exhibit varying degrees of biological activity, potentially influencing its pharmacological profile. Its identification and quantification are crucial in ensuring the purity of erythromycin products, as impurities can lead to adverse effects or reduced therapeutic efficacy. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to detect and characterize such impurities in pharmaceutical contexts.

CAS 40554-78-7

Erythromycin Impurity

11-Dehydroxy Erythromycin A

Ref: 4Z-E-2046